Related Experiment Video
Updated: Apr 10, 2026

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
Risk Factors for Colonization With Multidrug-Resistant Bacteria Among Patients Admitted to the Intensive Care Unit
Marion Angue1, Nicolas Allou1, Olivier Belmonte2
1Intensive Care Unit, CHU Félix Guyon, Saint-Denis, France.
Background:
Few national recommendations exist on management of patients returning from abroad and all focus on hospitalized patients. Our purpose was to compare, in an intensive care unit (ICU), the admission prevalence and acquisition of multidrug-resistant (MDR) bacteria carriage in patients with ("Abroad") or without ("Local") a recent stay abroad, and then identify the risk factors in "Abroad" patients.
Methods:
In this retrospective study, we reviewed charts of all the patients hospitalized in the ICU unit from January 2011 through July 2013 with hygiene samplings performed. We identified all patients who had stayed abroad ("Abroad") within 6 months prior to ICU admission.
Results:
Of 1,842 ICU patients, 129 (7%) "Abroad" patients were reported. In the "Abroad" group, the rate of MDR strain carriage was higher at admission (33% vs 6.7%, p < 0.001) and also more often diagnosed during the ICU stay (acquisition rate: 17% vs 5.2%, p < 0.001) than in "Local" patients. Risk factors associated with MDR bacteria carriage at admission in "Abroad" patients were diabetes mellitus [odds ratio (OR) 5.1 (1.7-14.8), p = 0.003] and "hospitalization abroad with antibiotic treatment" [OR 10.7 (4.2-27.3), p < 0.001]. Hospitalization abroad without antibiotic treatment was not identified as a risk factor.
Conclusions:
The main factor associated with MDR bacteria carriage after a stay abroad seems to be a hospitalization abroad only in case of antibiotic treatment abroad. Screening and isolation of "Abroad" patients should be recommended, even in case of a first negative screening.
Insights
Patients returning from abroad, especially those hospitalized and treated with antibiotics, have a higher risk of carrying multidrug-resistant (MDR) bacteria. Screening these travelers is recommended to prevent ICU infections.
Area of Science:
- Infectious Diseases
- Intensive Care Medicine
- Microbiology
Background:
- Limited national guidelines exist for managing patients returning from abroad, particularly for non-hospitalized individuals.
- Focus has been on hospitalized patients, leaving a gap in understanding risks for those admitted to intensive care units (ICUs).
Purpose of the Study:
- To compare the prevalence and acquisition of multidrug-resistant (MDR) bacteria carriage in ICU patients with recent stays abroad versus local patients.
- To identify specific risk factors for MDR bacteria carriage among patients with a history of travel abroad.
Main Methods:
- Retrospective chart review of 1,842 ICU patients from January 2011 to July 2013.
- Identification of patients with stays abroad within six months prior to ICU admission.
- Analysis of hygiene sampling data to determine MDR bacteria carriage and acquisition rates.
Main Results:
- 7% of ICU patients (129/1,842) had stayed abroad.
- The 'Abroad' group showed significantly higher MDR bacteria carriage at admission (33% vs. 6.7%) and acquisition during ICU stay (17% vs. 5.2%) compared to 'Local' patients.
- Key risk factors for MDR carriage in 'Abroad' patients included diabetes mellitus (OR 5.1) and hospitalization abroad with antibiotic treatment (OR 10.7).
Conclusions:
- Hospitalization abroad, particularly with antibiotic treatment, is a significant risk factor for MDR bacteria carriage in ICU patients.
- Screening and isolation of patients returning from abroad are recommended, even with initial negative screenings.
- This highlights the importance of considering travel history in infection control protocols for ICU patients.
More Related Videos
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Mechanism of Antibiotic Resistance in MRSA
Colonisation of Pathogens
Development of Antibiotic Resistance

